Cutting Edge in Nephrology

March 11, 2021 13:30-19:00 (UTC+1)
N.B Local timings differ for Iceland and Finland

Following registration, Astellas will send you a link to join the Symposium several days in advance of the meeting date. Please look out for this in your e-mail box.

Address Line 1

IMPORTANT: Your consent is voluntary and you can withdraw it at any time by clicking the “unsubscribe” link in any email communication you receive from Astellas going forward, or alternatively by sending an email to

Astellas is committed to protecting your personal information and will only use it in accordance with the applicable data privacy law and our Astellas Privacy Notice. For further information on how we process and protect your personal information and how you may exercise your data protection rights, please refer to our Privacy Notice at

If you have any questions or concerns, please contact us at

*) For the purpose of this consent, “Astellas Pharma Nordic” shall mean Astellas Pharma a/s (Denmark), Astellas Pharma AB (Sweden), Astellas Pharma (Norway) and Astellas Pharma A/S, filial in Finland (Finland).

** Astellas complies with the current Lif agreements with the Danish Regions and will not send any invitations directly to any hospital-employed HCPs where not allowed.


Astellas Pharma AB
Box 21046, 200 21 Malmö
Telefon 040-650 15 00

 Astellas Pharma
Vaisalantie 2–8, 02130 Espoo
Puhelin 09 8560 6000

Astellas Pharma a/s
Kajakvej 2, 2770 Kastrup
Telefon 4343 0355

Astellas Pharma
Hagaløkkveien 26, 1385 Asker
Telefon 66 76 46 00 

Astellas Pharma c/o Vistor hf.
Hörgatún 2, 210 Garðabær
Sími 535 7000